Antibiotic Utilization for Perianal Fistulizing Complications among Young Patients with Crohn's Disease.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42105935.
- Also identified by DOI 10.1016/j.jpeds.2026.115142.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To characterize patterns of antibiotic use among children with Crohn's disease and perianal fistulizing complications (PFCs) via a large, national administrative database. Retrospective analysis of US administrative claims including patients ≤21 years with Crohn's disease diagnosed 2009-2018 and 5-years of continuous enrollment. We evaluated patient characteristics, medication dispensing, and disease outcomes. Multivariable negative binomial regression evaluated predictors of days of antibiotics dispensed. Five thousand two hundred seventy-seven patients were included, with median age 16.0 years at diagnosis (55% male, 77% commercial insurance, 61% White). In total 17% developed PFC during enrollment. Antibiotic dispensing was common, 83% had at least 1 antibiotic prescription. Patients with PFC had more antibiotic days (median 67 days, IQR 26-138) compared with those without PFC (median 27 days, IQR 10-63; P = .001). In an adjusted model, patients with PFC had 90% more antibiotic dispensing than those without PFC. PFCs are common and are associated with greatly increased antibiotic dispensing with 1 in 12 patients filling >20 prescriptions during the 4-year study period. The optimal use of antibiotics remains unclear, and their extensive use in this population emphasizes the need for evidence-based treatment strategies and approaches to antibiotic stewardship.
Medical subject headings
- Crohn Disease
- Rectal Fistula
- Anti-Bacterial Agents
- Drug Utilization